Home/Filings/4/0001140361-23-000826
4//SEC Filing

HILL MATTHEW C 4

Accession 0001140361-23-000826

CIK 0001472091other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:59 PM ET

Size

5.4 KB

Accession

0001140361-23-000826

Insider Transaction Report

Form 4
Period: 2023-01-05
HILL MATTHEW C
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-01-05+161,200161,200 total
    Exercise: $11.61Exp: 2033-01-05Common Stock (161,200 underlying)
Footnotes (1)
  • [F1]This option, representing a right to purchase a total of 161,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.

Documents

1 file

Issuer

PDS Biotechnology Corp

CIK 0001472091

Entity typeother

Related Parties

1
  • filerCIK 0001278675

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:59 PM ET
Size
5.4 KB